AKBA vs BB · rev $160.2M vs P/E 117, rev $549.1M
Akebia Ther (AKBA) versus BlackBerry Ltd (BB) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Latest reported AKBA revenue for 2024-12-31 was $160.2M. Net income was -$69.4M. Revenue was down 17.7% from 2023-12-31 to 2024-12-31. AKBA currently screens at market cap $260.1M.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
AKBA currently screens at market cap $260.1M. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Not investment advice. Open the AKBA and BB stock pages for the full models.
Not investment advice.